1
|
Rebonato M, Pilati M, Milani SM, Bonnet D, Pascall E, Jones M, Betrian P, Bianco L, Lucron H, Hascoet S, Baruteau AE, Giugno L, Butera G. BeGraft Aortic Stents: A European Multi-Centre Experience Reporting Acute Safety and Efficacy Outcomes for the Treatment of Vessel Stenosis in Congenital Heart Diseases. J Cardiovasc Dev Dis 2024; 11:192. [PMID: 39057614 PMCID: PMC11276682 DOI: 10.3390/jcdd11070192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Revised: 06/18/2024] [Accepted: 06/18/2024] [Indexed: 07/28/2024] Open
Abstract
BACKGROUND Stent implantation has become the preferred method of treatment for treating vessel stenosis in congenital heart diseases. The availability of covered stents may decrease complications and have an important role in the management of patients with complex anatomy. AIM This study aims to evaluate the feasibility and safety of the pre-mounted cobalt-chromium stent-graft-covered ePTFE Aortic BeGraft in a broad spectrum of vascular lesions. METHODS This is a multicenter retrospective results analysis of 107 implanted BeGraft stents between 2016 and 2022 in six different European centers. RESULTS One hundred and four patients with a mean age of thirteen years (range 1-70 years) and with the body weight of 56.5 kg (range 11-115 kg) underwent the BeGraft stent implantation. Stents were implanted in the following conditions: aortic coarctation (74 patients), RVOT dysfunction (12 patients), Fontan circulation (7 patients), and miscellaneous (11 subjects with complex CHD). All the stents were implanted successfully. The median stent diameter was 16 mm (range 7-24 mm), and the median length was 39 mm (range 19-49 mm). Major complications occurred in five subjects (4.7%). During a median follow-up of fourteen (1-70) months, stents' re-dilatation was performed in five patients. CONCLUSIONS The BeGraft stent can be used safely and effectively in a wide spectrum of congenital heart diseases. Whether these good results will be stable in the longer term still needs to be investigated in a follow-up given its recent introduction into clinical practice, in particular regarding stent fracture or neointimal proliferation.
Collapse
Affiliation(s)
- Micol Rebonato
- Department of Pediatric Cardiology, Cardiac Surgery and Heart Lung Transplantation, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.P.); (G.B.)
| | - Mara Pilati
- Department of Pediatric Cardiology, Cardiac Surgery and Heart Lung Transplantation, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.P.); (G.B.)
| | - Sophie Malekzadeh Milani
- Centre de Référence Malformations Cardiaques Congénitales Complexes—M3C, Hôpital Universitaire Necker Enfants Malades, F-75015 Paris, France; (S.M.M.); (D.B.)
| | - Damien Bonnet
- Centre de Référence Malformations Cardiaques Congénitales Complexes—M3C, Hôpital Universitaire Necker Enfants Malades, F-75015 Paris, France; (S.M.M.); (D.B.)
| | - Emma Pascall
- Guy’s and St Thomas’ NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK; (E.P.); (M.J.)
| | - Matthew Jones
- Guy’s and St Thomas’ NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK; (E.P.); (M.J.)
| | - Pedro Betrian
- Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain; (P.B.); (L.B.)
| | - Lisa Bianco
- Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain; (P.B.); (L.B.)
| | - Hugues Lucron
- Hôpital Marie-Lannelongue, F-92350 Le Plessis-Robinson, France; (H.L.)
| | - Sebastien Hascoet
- Hôpital Marie-Lannelongue, F-92350 Le Plessis-Robinson, France; (H.L.)
- Groupe Hospitalier Paris Saint Joseph, F-75014 Paris, France
| | - Alban-Elouen Baruteau
- Department of Pediatric Cardiology and Pediatric Cardiac Surgery, CHU Nantes, Nantes Université, FHU PRECICARE, F-44000 Nantes, France;
- CIC FEA 1413, INSERM, CHU Nantes, Nantes Université, F-44000 Nantes, France
- L’Institut du Thorax, INSERM, CNRS, CHU Nantes, Nantes Université, F-44000 Nantes, France
- UMR 1280, PhAN, INRAE, Nantes Université, F-44000 Nantes, France
| | | | - Gianfranco Butera
- Department of Pediatric Cardiology, Cardiac Surgery and Heart Lung Transplantation, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; (M.P.); (G.B.)
| |
Collapse
|
2
|
Pollorsi G, Danzer D, Murith N, Huber C, Mugnai D. Iliac occlusion due to covered stent deformation following abdominal massages. J Vasc Surg Cases Innov Tech 2022; 8:187-189. [PMID: 35434435 PMCID: PMC9006474 DOI: 10.1016/j.jvscit.2022.02.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2020] [Accepted: 02/09/2022] [Indexed: 11/04/2022] Open
Abstract
Extrinsic compression is a potential cause of stent failure. We have described the case of a 65-year-old paraplegic patient with acute right leg ischemia. His medical history was relevant for aortobifemoral bypass, followed by kissing covered stent reconstruction of a proximal anastomotic false aneurysm. The computed tomography scan showed collapse of the right iliac covered stent with ipsilateral iliofemoral graft thrombosis and partial collapse of the left iliac covered stent. He underwent emergent right iliac limb open thrombectomy and redo covered stent relining. The cause of compression was found to be daily deep abdominal massages for intestinal evacuation. The endovascular device should be tailored to the patient's particularities.
Collapse
|
3
|
Sherif NEE, Taggart NW. Covered Stents in the Management of Aortic Coarctation and Right Ventricular Outflow Tract Obstruction. Curr Cardiol Rep 2022; 24:51-58. [PMID: 35028814 DOI: 10.1007/s11886-021-01623-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 09/30/2021] [Indexed: 01/28/2023]
Abstract
PURPOSE OF REVIEW To review the use of covered stents in the treatment of coarctation of the aorta (CoA) and right ventricle to pulmonary artery (RV-PA) conduit obstruction. RECENT FINDINGS The only commercially available covered stent approved for treatment of CoA and dysfunctional RV-PA conduits is the covered Cheatham-Platinum stent (CCPS). Early outcomes have demonstrated its safety and have suggested its efficacy in treating or preventing aortic wall injury (AWI) or conduit disruption. A recent study of CCPS use for CoA reported a progressive risk of stent fracture over time and a risk of AWI despite the purported protection that the CCPS provides. The use of other covered stents has been reported, but large, systematic studies are lacking. CCPS use may reduce but does not eliminate the risk of conduit disruption or AWI. Structural limitations of the CCPS may predispose it to stent fracture. Access to a broad range of covered stents continues to be an unmet need in the field of congenital interventional cardiology.
Collapse
Affiliation(s)
- Nibras E El Sherif
- Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA
| | - Nathaniel W Taggart
- Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
| |
Collapse
|
4
|
Topcuoglu OM, Altay CM, Alpar A, Kucukay F. Predictors of long-term outcomes after polytetrafluoroethylene-covered stent-graft repair of peripheral arterial aneurysms, pseudo-aneurysms, and arterio-venous fistulas. Vascular 2020; 28:355-359. [PMID: 32063137 DOI: 10.1177/1708538120903960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVES To evaluate the primary patency rate at three years for the infra-aortic peripheral arterial pathologies treated with polytetrafluoroethylene-covered stent-grafts. METHODS Patients treated with self-expandable polytetrafluoroethylene-covered stent-grafts for infra-aortic peripheral arterial aneurysms, pseudo-aneurysms, and arterio-venous fistulas were evaluated retrospectively. A total of 48 patients (35 male, 13 female; mean age: 53.8 ± 13.5) were included with 29.0 ± 16.5 months (median 27, range 4-70) mean follow-up period. The primary objective was to determine the primary patency rate at three years. The secondary objectives were to compare type and localization of pathology, and length and diameter of the stent-grafts with primary patency rate. Kaplan-Meier test was used as the main statistical method. RESULTS Overall mean primary patency rate at three years was 77.10%. Polytetrafluoroethylene-covered stent-graft implantation in aneurysms had worse primary patency rate than pseudo-aneurysms and arterio-venous fistulas (66.6%, P = 0.03; 76.9%, P = 0.03; 88.2%, P = 0.01, respectively). Stent-graft location, length, and diameter are not associated with primary patency rate (P > 0.05) but stent diameter is associated with better primary assisted and secondary patency rates (P < 0.05). CONCLUSIONS Pathology of the lesion is associated with the long-term primary patency rate of polytetrafluoroethylene-covered stent-grafts but not the stent-graft location, length, or diameter. Stent diameter is associated with primary assisted and secondary patency rates.
Collapse
Affiliation(s)
| | - Cetin Murat Altay
- Department of Radiology, Karabuk Educational and Research Hospital, Karabuk, Turkey
| | - Ayhan Alpar
- Department of Radiology, Sancaktepe Educational and Research Hospital, Istanbul, Turkey
| | - Fahrettin Kucukay
- Department of Radiology, Osmangazi University Medical School, Eskisehir, Turkey
| |
Collapse
|
5
|
van der Burg JJ, Warmerdam EG, Krings GJ, Meijboom FJ, van Dijk AP, Post MC, Veen G, Voskuil M, Sieswerda GT. Effect of stent implantation on blood pressure control in adults with coarctation of the aorta. CARDIOVASCULAR REVASCULARIZATION MEDICINE 2018; 19:944-950. [PMID: 29752138 DOI: 10.1016/j.carrev.2018.03.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Revised: 03/21/2018] [Accepted: 03/22/2018] [Indexed: 01/16/2023]
Abstract
BACKGROUND Stenting of coarctation of the aorta (CoA) generally results in good angiographic results and a decrease in transcoarctation pressure gradient. However, effect on blood pressure control is less clear. The goal of the current retrospective analysis was to investigate the effects of CoA stenting on blood pressure control. METHODS A retrospective analysis was conducted in consecutive adult patients with a CoA who underwent a percutaneous intervention at one of the three participating hospitals. Measurements included office blood pressure, invasive peak-to-peak systolic pressure over the CoA, diameter of the intima lumen at the narrowest part of the CoA and use of medication. The follow-up data were obtained, based on the most recent examination date. RESULTS There were 26 native CoA and 17 recurrent CoAs (total n = 43). Seven of them underwent two procedures. Mean peak-to-peak gradient decreased from 27 mmHg to 3 mmHg (p < 0.001), and minimal diameter increased from a mean of 11 mm to 18 mm (p < 0.001). Mean systolic blood pressure decreased from 151 ± 18 mmHg to 135 ± 19 mmHg at first follow-up of 3.8 ± 1.9 months and 137 ± 22 mmHg at latest follow-up of 19.5 ± 10.9 months (p = 0.001 and p = 0.009, compared to baseline, respectively). The total number of hypertensive patients decreased from 74% to 27% at latest follow-up. No significant change in antihypertensive medication was observed. CONCLUSION A clinically significant decrease in systolic blood pressure of approximately 16 mmHg was shown after (re)intervention in CoA patients, which sustained at follow-up. This sustained decrease of blood pressure can be expected to lead to less future adverse cardiovascular events.
Collapse
Affiliation(s)
- Jennifer J van der Burg
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands; VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands
| | - Evangeline G Warmerdam
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands
| | - Gregor J Krings
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands
| | - Folkert J Meijboom
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands
| | - Arie P van Dijk
- Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands
| | - Marco C Post
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands; St Antonius Hospital, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands
| | - Gerrit Veen
- VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands
| | - Michiel Voskuil
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands
| | - Gertjan Tj Sieswerda
- University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands.
| |
Collapse
|
6
|
Liu X, Zhang Y, Wang S, Lei Z, Li X, Fan D. The use of expanded polytetrafluoroethylene in depressed deformities of the face. Exp Ther Med 2016; 12:3151-3154. [PMID: 27882130 PMCID: PMC5103759 DOI: 10.3892/etm.2016.3771] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2015] [Accepted: 06/03/2016] [Indexed: 11/06/2022] Open
Abstract
Expanded polytetrafluoroethylene (ePTFE) has been extensively used for facial soft tissue augmentation procedures, and is regarded as safe and reliable and suitable as a permanent implant. This implant is generally used in the lower third of the face for lips filling, nasal augmentation, nasolabial folds and chin augmentation, and rarely for congenital or acquired depressed deformities of the face. The aim of the present study was to assess the effects of ePTFE in congenital or acquired depressed deformities of the face. From September, 2008 to January, 2014, 26 patients were implanted with the material ePTFE to correct depressed deformities of the face. The average age at operation was 23.2 years, with a range of 17-45 years. The depressed deformities were lateralized. The follow-up period was 6-18 months (average 9 months). The etiologies of the depressed deformities included stable hemifacial atrophy (3 cases), craniofacial microsomia (13 cases), bony depression after trauma (8 cases), and other unclear reasons (2 cases). The operations were performed under local anesthesia. ePTFE was inserted in different tissue planes that varied among the different subanatomical areas in the face: beneath the superficial temporal fascia in the temporal area, and on the surface of the superficial musculoaponeurotic system in the zygomatic area, cheek and mandibular area. All of the patients were followed up. Most of the patients [25 of 26 patients (96.2%)] were satisfied with the results, while 1 patient (3.8%) was not satisfied for incomplete correction of the depressed deformity. In conclusion, aside from lipofilling and a free flap transfer, the results showed that ePTFE was an alternative treatment for facial depressed deformity.
Collapse
Affiliation(s)
- Xiaowei Liu
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| | - Yiming Zhang
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| | - Shaoliang Wang
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| | - Zeyuan Lei
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| | - Xiang Li
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| | - Dongli Fan
- Department of Plastic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China
| |
Collapse
|
7
|
Lee ML, Chiu IS, Yang AD. Middle Aortic Syndrome Treated by Implantation of an Advanta V12 Large Diameter Stent. Arq Bras Cardiol 2016; 106:73-5. [PMID: 26815649 PMCID: PMC4728599 DOI: 10.5935/abc.20150065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2015] [Accepted: 03/11/2015] [Indexed: 11/20/2022] Open
Affiliation(s)
- Meng-Luen Lee
- Department of Pediatrics, Changhua Christian Children's Hospital, Changhua, Taiwan
| | - Ing-Sh Chiu
- Department of Surgery, Changhua Christian Children's Hospital, Changhua, Taiwan
| | - Albert D Yang
- Medical Imaging, Changhua Christian Children's Hospital, Changhua, Taiwan
| |
Collapse
|
8
|
Erben Y, Oderich GS, Duncan AA. Endovascular repair of aortic coarctation pseudoaneurysm using an off-label "hourglass" stent-graft configuration. J Endovasc Ther 2015; 22:460-5. [PMID: 25878022 DOI: 10.1177/1526602815581595] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
PURPOSE To describe an endovascular technique for treating a pseudoaneurysm of the thoracic aorta using an off-label "hourglass" stent-graft configuration. CASE REPORT A 68-year-old patient with prior open thoracic aorta coarctation repair presented with recurrent coarctation and concurrent enlarging 6-cm bilobed pseudoaneurysm involving the previous anastomosis. There was significant discrepancy in the aortic diameter (measured from wall to wall) proximal to the coarctation (14 mm), at the narrowest segment (8 mm), and distally (23 mm). Endovascular repair included deployment of an inverted iliac limb proximally, followed by an inverted aortic converter distally, giving an "hourglass" configuration. There were no perioperative or stent-graft-related complications at 5-year follow-up. The aneurysm regressed from 61 to 25 mm. CONCLUSION The use of inverted stent-grafts can allow tapering and flaring to adapt to discrepant aortic diameters. This technique may be useful in select patients with prior coarctation repair who do not need excessive dilation of the narrow aortic segment.
Collapse
Affiliation(s)
- Young Erben
- Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA
| | - Gustavo S Oderich
- Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA
| | - Audra A Duncan
- Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA
| |
Collapse
|
9
|
Hascoët S, Baruteau A, Jalal Z, Mauri L, Acar P, Elbaz M, Boudjemline Y, Fraisse A. Stents in paediatric and adult congenital interventional cardiac catheterization. Arch Cardiovasc Dis 2014; 107:462-75. [PMID: 25128078 DOI: 10.1016/j.acvd.2014.06.005] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/01/2014] [Revised: 06/12/2014] [Accepted: 06/13/2014] [Indexed: 11/15/2022]
Abstract
A 'stent' is a tubular meshed endoprosthesis that has contributed to the development of interventional catheterization over the past 30 years. In congenital heart diseases, stents have offered new solutions to the treatment of congenital vessel stenosis or postsurgical lesions, to maintain or close shunt patency, and to allow transcatheter valve replacement. First, stents were made of bare metal. Then, stent frameworks evolved to achieve a better compromise between radial strength and flexibility. However, almost all stents used currently in children have not been approved for vascular lesions in children and are therefore used 'off-label'. Furthermore, the inability of stents to follow natural vessel growth still limits their use in low-weight children and infants. Recently, bioresorbable stents have been manufactured and may overcome this issue; they are made from materials that may dissolve or be absorbed in the body. In this review, we aim to describe the history of stent development, the technical characteristics of stents used currently, the clinical applications and results, and the latest technological developments and perspectives in paediatric and adult congenital cardiac catheterization.
Collapse
Affiliation(s)
- Sebastien Hascoët
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C CHU Toulouse, Paediatric and Congenital Cardiology, Children's Hospital, Paul-Sabatier University, 31059 Toulouse, France; Inserm UMR 1048, Équipe 8, I2MC, institut des maladies métaboliques et cardiovasculaires, Paul-Sabatier University, 31432 Toulouse, France; CHU Toulouse, Department of Cardiology, Rangueil Hospital, Paul-Sabatier University, 31400 Toulouse, France.
| | - Alban Baruteau
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C Marie-Lannelongue Hospital, Paediatric and Congenital Cardiac Surgery, Paris Sud University, 92350 Paris, France; Inserm UMR 1087, CNRS UMR6291, institut du thorax, Nantes University, 70721 Nantes, France
| | - Zakaria Jalal
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C CHU Bordeaux, Paediatric and Congenital Cardiology, Haut l'Évêque Hospital, 33600 Bordeaux, France
| | - Lucia Mauri
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C CHU Marseille, Paediatric and Congenital Cardiology, La Timone Hospital, 13385 Marseille, France
| | - Philippe Acar
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C CHU Toulouse, Paediatric and Congenital Cardiology, Children's Hospital, Paul-Sabatier University, 31059 Toulouse, France
| | - Meyer Elbaz
- CHU Toulouse, Department of Cardiology, Rangueil Hospital, Paul-Sabatier University, 31400 Toulouse, France
| | - Younes Boudjemline
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C Necker Hospital for Sick Children, Paediatric Cardiology, Paris 5 René Descartes University, 75015 Paris, France; M3C Georges Pompidou European Hospital, Adult Congenital Cardiology, 75015 Paris, France
| | - Alain Fraisse
- Groupe de cathétérisme interventionnel pédiatrique et congénital, filiale de cardiologie pédiatrique et congénitale de la Société française de cardiologie, France; M3C CHU Marseille, Paediatric and Congenital Cardiology, La Timone Hospital, 13385 Marseille, France
| |
Collapse
|
10
|
Vanagt WY, Cools B, Boshoff DE, Frerich S, Heying R, Troost E, Louw J, Eyskens B, Budts W, Gewillig M. Use of covered Cheatham-Platinum stents in congenital heart disease. Int J Cardiol 2014; 175:102-7. [DOI: 10.1016/j.ijcard.2014.04.271] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/27/2013] [Revised: 04/17/2014] [Accepted: 04/30/2014] [Indexed: 11/30/2022]
|
11
|
Aortic coarctation associated with aortic valve stenosis and mitral regurgitation in an adult patient: a two-stage approach using a large-diameter stent graft. Ann Vasc Surg 2013; 28:494.e9-14. [PMID: 24332897 DOI: 10.1016/j.avsg.2013.04.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2013] [Revised: 04/21/2013] [Accepted: 04/27/2013] [Indexed: 11/21/2022]
Abstract
We report a case of a staged surgical and endovascular management in a 62-year-old woman with aortic coarctation associated with aortic valve stenosis and mitral regurgitation. The patient was admitted for severe aortic valve stenosis and mitral valve incompetence. During hospitalization and preoperative imaging, a previously undiagnosed aortic coarctation was discovered. The patient underwent a 2-stage approach that combined a Bentall procedure and mitral valve replacement in the first stage, followed by correction of the aortic coarctation by percutaneous placement of an Advanta V12 large-diameter stent graft (Atrium, Mijdrecht, The Netherlands) which to our knowledge has not been used in an adult patient with this combination of additional cardiac comorbidities. A staged approach combining surgical treatment first and endovascular placement of an Advanta V12 stent graft in the second stage can be effective and safe in adult patients with coarctation of the aorta and additional cardiac comorbidities.
Collapse
|
12
|
Hayes N, Podnar T, Qureshi S. Collapse of the advanta V12 large diameter covered stent following implantation for aortic coarctation. Catheter Cardiovasc Interv 2013; 83:109-14. [DOI: 10.1002/ccd.25139] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2013] [Revised: 05/14/2013] [Accepted: 07/21/2013] [Indexed: 11/10/2022]
Affiliation(s)
- Nicholas Hayes
- Evelina Children's Hospital; Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London E1 7EH United Kingdom
| | - Tomaž Podnar
- Department of Paediatrics; University Medical Center Ljubljana; Bohoričeva 20, 1000 Ljubljana Slovenia
| | - Shakeel Qureshi
- Evelina Children's Hospital; Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London E1 7EH United Kingdom
| |
Collapse
|
13
|
OHNO NAOKI, CHATURVEDI RAJIV, LEE KYONGJIN, HORLICK ERICM, OSTEN MARKD, BENSON LEEN. Experience With the Atrium Advanta Covered Stent for Aortic Obstruction. J Interv Cardiol 2013; 26:411-6. [DOI: 10.1111/joic.12043] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Affiliation(s)
- NAOKI OHNO
- Department of Pediatrics, Division of Cardiology, The Labatt Family Heart Centre; The Hospital for Sick Children; Toronto Ontario Canada
| | - RAJIV CHATURVEDI
- Department of Pediatrics, Division of Cardiology, The Labatt Family Heart Centre; The Hospital for Sick Children; Toronto Ontario Canada
| | - KYONG-JIN LEE
- Department of Pediatrics, Division of Cardiology, The Labatt Family Heart Centre; The Hospital for Sick Children; Toronto Ontario Canada
| | - ERIC M. HORLICK
- Division of Cardiology, Toronto General Hospital; The University Health Network, The University of Toronto School of Medicine; Toronto Ontario Canada
| | - MARK D. OSTEN
- Division of Cardiology, Toronto General Hospital; The University Health Network, The University of Toronto School of Medicine; Toronto Ontario Canada
| | - LEE N. BENSON
- Department of Pediatrics, Division of Cardiology, The Labatt Family Heart Centre; The Hospital for Sick Children; Toronto Ontario Canada
| |
Collapse
|